News

Could Galectin-3 Predict Who Responds Best to G...

GLP-1 receptor agonists have transformed the treatment of obesity and type 2 diabetes. Medications such as liraglutide, semaglutide, and tirzepatide are increasingly used as frontline therapies due to their remarkable...

Groundbreaking Sepsis Study Reveals Potential L...

A groundbreaking new translational study published in MedComm adds important new evidence highlighting galectin-3 (Gal-3) as a central upstream regulator —and key therapeutic target—in life threatening sepsis (1). Today, sepsis...

Galectin-3, Neuroinflammation, and Mental Healt...

A growing body of published research and clinical practice is reframing mental health conditions by applying an immuno-inflammatory perspective. Within this fast-growing body of research, galectin-3 (Gal-3) is emerging as...

Gut Dysbiosis and Thrombosis: Rethinking Chroni...

There is a familiar patient in naturopathic and integrative medicine practice: The one with chronic bloating, dysregulated satiety, postprandial and other GI discomfort, alternating stool patterns, food reactivity, fatigue, and related concerns. They could be post-viral, dealing with chronic infections, mold-sensitive, autoimmune, or all of the...

Terminalia chebula (Chebulic Myrobalan) Gains R...

Terminalia chebula, also known as Chebulic Myrobalan or Haritaki, has long been valued in Ayurvedic medicine, primarily for digestive and detoxification support. Traditionally included in the well-known Triphala formulation, the fruit has been associated...

Prostate Health Clinical Insights — Heavy Metal...

In our integrative health work, environmental toxicants — particularly heavy metals — are increasingly shown to act as drivers of today’s most serious health conditions, including prostate cancer and prostate...